NeoGenomics Correlations
| NEO Stock | USD 12.93 0.44 3.52% |
The current 90-days correlation between NeoGenomics and Exagen Inc is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeoGenomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeoGenomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
NeoGenomics Correlation With Market
Average diversification
The correlation between NeoGenomics and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NeoGenomics and DJI in the same portfolio, assuming nothing else is changed.
NeoGenomics | Build AI portfolio with NeoGenomics Stock |
Moving together with NeoGenomics Stock
| 0.8 | NPTH | NeuPath Health | PairCorr |
| 0.64 | CAH | Cardinal Health | PairCorr |
| 0.65 | HCA | HCA Holdings | PairCorr |
| 0.85 | NHC | National HealthCare | PairCorr |
| 0.87 | DR | Medical Facilities | PairCorr |
| 0.83 | BIMI | Bimi International | PairCorr |
| 0.84 | WMT | Walmart Common Stock Aggressive Push | PairCorr |
| 0.9 | SAR | Saratoga Investment Corp | PairCorr |
Moving against NeoGenomics Stock
| 0.87 | 300015 | Aier Eye Hospital | PairCorr |
| 0.79 | SPI | Spire Healthcare | PairCorr |
| 0.74 | 600763 | Top Choice Medical | PairCorr |
| 0.73 | 301267 | Huaxia Eye Hospital | PairCorr |
| 0.54 | OPT | Optima Health plc | PairCorr |
| 0.42 | LH | Laboratory | PairCorr |
| 0.39 | PHA | Premier Health | PairCorr |
| 0.37 | UNH | UnitedHealth Group CDR Earnings Call Today | PairCorr |
| 0.31 | UNH | UnitedHealth Group | PairCorr |
| 0.8 | ACHC | Acadia Healthcare Downward Rally | PairCorr |
| 0.75 | WELL | WELL Health Technologies | PairCorr |
| 0.74 | JD | JD Inc Adr | PairCorr |
| 0.61 | CRVL | CorVel Corp | PairCorr |
| 0.55 | PINC | Premier | PairCorr |
| 0.45 | HNHPF | Hon Hai Precision | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between NeoGenomics Stock performing well and NeoGenomics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NeoGenomics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| XGN | 2.39 | (1.25) | 0.00 | (0.68) | 0.00 | 3.11 | 13.49 | |||
| MDXH | 2.91 | (0.35) | 0.00 | (0.14) | 0.00 | 7.53 | 19.70 | |||
| STXS | 2.65 | (0.44) | 0.00 | (0.16) | 0.00 | 4.69 | 18.81 | |||
| ACRS | 4.02 | 0.54 | 0.12 | 0.62 | 4.13 | 8.84 | 26.60 | |||
| QTRX | 3.10 | 0.22 | 0.09 | 0.21 | 2.85 | 7.89 | 32.49 | |||
| SGMT | 3.45 | (0.60) | 0.00 | (0.13) | 0.00 | 6.39 | 36.94 | |||
| SMTI | 2.80 | (0.40) | 0.00 | (0.44) | 0.00 | 6.96 | 31.68 | |||
| ARCT | 4.35 | (1.33) | 0.00 | (0.33) | 0.00 | 7.42 | 59.77 | |||
| HUMA | 3.69 | (0.72) | 0.00 | (0.18) | 0.00 | 8.16 | 22.74 | |||
| TKNO | 2.81 | (0.38) | 0.00 | (0.15) | 0.00 | 6.29 | 21.07 |
NeoGenomics Corporate Management
| Nathan MD | Vice Services | Profile | |
| George Cardoza | Pres Operations | Profile | |
| Gary Passman | Chief Officer | Profile | |
| Alicia Olivo | General Development | Profile | |
| Andrew Lukowiak | Chief Officer | Profile | |
| Cynthia Dieter | Chief Officer | Profile |